Skip to main content

Bupropion / dextromethorphan Side Effects

Medically reviewed by Drugs.com. Last updated on Aug 1, 2023.

Applies to bupropion / dextromethorphan: oral tablet extended release.

Warning

Oral route (Tablet, Extended Release)

Warning: Suicidal Thoughts and BehaviorsAntidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and emergence of suicidal thoughts and behaviors. Dextromethorphan hydrobromide/buPROPion hydrochloride is not approved for use in pediatric patients.

Serious side effects

Along with its needed effects, bupropion / dextromethorphan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking bupropion / dextromethorphan:

Less common

Incidence not known

Get emergency help immediately if any of the following symptoms of overdose occur while taking bupropion / dextromethorphan:

Symptoms of overdose

Other side effects

Some side effects of bupropion / dextromethorphan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

Incidence not known

For Healthcare Professionals

Applies to bupropion / dextromethorphan: oral tablet extended release.

General

The most common adverse reactions reported were dizziness, headache, diarrhea, somnolence, dry mouth, sexual dysfunction, and hyperhidrosis. In 1 study, 4% of patients treated with this drug discontinued therapy due to adverse reactions; the adverse reaction that led to discontinuation most often was anxiety.[Ref]

Cardiovascular

Bupropion:

-Frequency not reported: Elevated blood pressure, hypertension

-Postmarketing reports: Complete atrioventricular block, extrasystoles, hypotension, hypertension (some severe cases), phlebitis[Ref]

Dermatologic

Common (1% to 10%): Hyperhidrosis

Bupropion:

-Postmarketing reports: Rash, alopecia, angioedema, exfoliative dermatitis, hirsutism, Stevens-Johnson syndrome[Ref]

Endocrine

Bupropion:

-Postmarketing reports: Syndrome of inappropriate antidiuretic hormone secretion, gynecomastia[Ref]

Gastrointestinal

Very common (10% or more): Nausea (up to 13%)

Common (1% to 10%): Diarrhea, dry mouth, constipation

Bupropion:

-Postmarketing reports: Colitis, esophagitis, gastrointestinal hemorrhage, gum hemorrhage, intestinal perforation, pancreatitis, stomach ulcer

Dextromethorphan:

-Postmarketing reports: Nausea, vomiting, stomach pain[Ref]

Genitourinary

Bupropion:

-Postmarketing reports: Glycosuria, abnormal ejaculation, cystitis, dyspareunia, dysuria, painful erection, salpingitis, urinary incontinence, urinary retention, vaginitis[Ref]

Hematologic

Altered prothrombin time and/or INR (infrequently associated with hemorrhagic/thrombotic complications) were observed when bupropion was coadministered with warfarin.[Ref]

Bupropion:

-Postmarketing reports: Anemia, leukocytosis, leukopenia, lymphadenopathy, pancytopenia, thrombocytopenia, altered prothrombin time, altered INR, hemorrhagic/thrombotic complications[Ref]

Hepatic

Bupropion:

-Postmarketing reports: Hepatitis[Ref]

Hypersensitivity

Bupropion:

-Postmarketing reports: Delayed hypersensitivity, serum sickness-like symptoms[Ref]

Arthralgia, myalgia, fever with rash, and other symptoms suggestive of delayed hypersensitivity have been reported during postmarketing experience with bupropion; such symptoms have resembled serum sickness.[Ref]

Metabolic

Common (1% to 10%): Decreased appetite

Bupropion:

-Postmarketing reports: Hyperglycemia, hypoglycemia, hyponatremia[Ref]

Musculoskeletal

Common (1% to 10%): Arthralgia

Bupropion:

-Postmarketing reports: Arthralgia, myalgia, muscle rigidity/fever/rhabdomyolysis, muscle weakness[Ref]

Nervous system

Very common (10% or more): Dizziness (up to 16%)

Common (1% to 10%): Headache, somnolence, paresthesia (includes paresthesia, hypoesthesia)

Bupropion:

-Uncommon (0.1% to 1%): Seizure

-Postmarketing reports: Abnormal electroencephalogram, akinesia, aphasia, coma, dysarthria, extrapyramidal syndrome (dyskinesia, dystonia, hypokinesia, parkinsonism), neuralgia, neuropathy, unmasking tardive dyskinesia

Dextromethorphan:

-Postmarketing reports: Drowsiness, dizziness[Ref]

Ocular

Common (1% to 10%): Vision blurred

Bupropion:

-Frequency not reported: Pupillary dilation, angle closure glaucoma

-Postmarketing reports: Increased intraocular pressure, mydriasis[Ref]

Other

Common (1% to 10%): Fatigue (includes fatigue, lethargy)

Bupropion:

-Postmarketing reports: Fever, deafness, menopause[Ref]

Psychiatric

Common (1% to 10%): Sexual dysfunction (includes orgasm abnormal, erectile dysfunction, libido decreased, anorgasmia), anxiety, insomnia

Bupropion:

-Frequency not reported: Neuropsychiatric signs/symptoms (including delusions, hallucinations, psychosis, concentration disturbance, paranoia, confusion)

-Postmarketing reports: Aggression, agitation, completed suicide, delirium, delusions, depression, euphoria, hallucinations, homicidal ideation, hostility, increased libido, manic reaction, panic, paranoid ideation, psychosis, restlessness, suicide ideation, suicide attempt

Dextromethorphan:

-Postmarketing reports: Nervousness/restlessness

Antidepressant drugs:

-Frequency not reported: Suicidal thoughts, suicidal behaviors, manic/mixed/hypomanic episode precipitated[Ref]

Respiratory

Bupropion:

-Postmarketing reports: Pulmonary embolism, pneumonia[Ref]

Frequently asked questions

References

1. Product Information. Auvelity (bupropion-dextromethorphan). Axsome Therapeutics, Inc. 2022;1.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.